79 related articles for article (PubMed ID: 34844191)
21. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
[TBL] [Abstract][Full Text] [Related]
22. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
[TBL] [Abstract][Full Text] [Related]
23. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
24. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
Lee JS; Han D; Kim SY; Hong KH; Jang MJ; Kim MJ; Kim YG; Park JH; Cho SI; Park WB; Lee KB; Shin HS; Oh HS; Kim TS; Park SS; Seong MW
Proteomics; 2021 Jun; 21(11-12):e2000278. PubMed ID: 33945677
[TBL] [Abstract][Full Text] [Related]
26. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
Shrivastava S; Palkar S; Shah J; Rane P; Lalwani S; Mishra AC; Arankalle VA
Am J Trop Med Hyg; 2021 Jun; 105(2):401-406. PubMed ID: 34138748
[TBL] [Abstract][Full Text] [Related]
27. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
Front Immunol; 2021; 12():684014. PubMed ID: 34194438
[TBL] [Abstract][Full Text] [Related]
28. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children.
Sananez I; Raiden SC; Algieri SC; Uranga M; Grisolía NA; Filippo D; De Carli N; Lalla SD; Cairoli H; Chiolo MJ; Meregalli CN; Cohen E; Mosquera G; Marcó Del Pont M; Giménez LI; Gregorio G; Sarli M; Alcalde AL; Davenport C; Bruera MJ; Simaz N; Pérez MF; Nivela V; Bayle C; Alvarez L; Revetria M; Tuccillo P; Agosta MT; Pérez H; Nova SV; Suárez P; Takata EM; García M; Lattner J; Rolón MJ; Coll P; Salvatori M; Piccardo C; Russo C; Varese A; Seery V; Holgado MP; Polo ML; Ceballos A; Nuñez M; Penedo JMG; Ferrero F; Geffner J; Arruvito L
EBioMedicine; 2021 Oct; 72():103615. PubMed ID: 34649078
[TBL] [Abstract][Full Text] [Related]
29. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
30. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Immune Profiling Reveals CD56
Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes.
Gummesson A; Björnson E; Fagerberg L; Zhong W; Tebani A; Edfors F; Schmidt C; Lundqvist A; Adiels M; Bäckhed F; Schwenk JM; Jansson PA; Uhlén M; Bergström G
EBioMedicine; 2021 Jan; 63():103147. PubMed ID: 33279861
[TBL] [Abstract][Full Text] [Related]
33. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
35. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults.
Petrara MR; Bonfante F; Costenaro P; Cantarutti A; Carmona F; Ruffoni E; Di Chiara C; Zanchetta M; Barzon L; Donà D; Da Dalt L; Bortolami A; Pagliari M; Plebani M; Rossi P; Cotugno N; Palma P; Giaquinto C; De Rossi A
Front Immunol; 2021; 12():741796. PubMed ID: 34659235
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
37. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
Front Immunol; 2021; 12():664619. PubMed ID: 34305895
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
39. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
[TBL] [Abstract][Full Text] [Related]
40. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
